CVS Health Corp (CVS) Stock

CVS Health Corp Stock Details, Movements and Public Alerts

Stock Details

CVS Health Corp (CVS), a prominent company in the trade & services sector within the retail-drug stores and proprietary stores industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $66.06. Over the past 52 weeks, it has ranged between $42.57 and $72.51. This places the current price at 91.1% of its 52-week high and 55.2% above its 52-week low. Recent trading volume was recorded at 153. The 14-day Relative Strength Index (RSI) stands at 49.61, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $65.20 by 1.32%. Similarly, it is above its 200-day moving average of $58.59 by 12.75%. The MACD histogram is 0.29, indicating bullish momentum (MACD Line: -0.56, Signal Line: -0.85).

52-Week High

$72.51

52-Week Low

$42.57

Volume

153

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

15.28

Near market average

Forward P/E

10.89

Earnings expected to grow

PEG Ratio

0.67

Potentially undervalued

Price to Book

1.05

EV/EBITDA

10.09

EPS (TTM)

$4.19

Price to Sales

0.21

Beta

0.60

Less volatile than market

Is CVS's P/E ratio considered high or low?
CVS Health Corp's current P/E ratio is 15.28, which is near the market average, suggesting the stock is fairly valued relative to its earnings.
How does CVS's Forward P/E compare to its current P/E?
CVS Health Corp's current P/E is 15.28 and its Forward P/E is 10.89. The lower Forward P/E suggests analysts expect earnings to grow in the coming year, potentially making the stock more attractively valued based on future earnings.
What does CVS's PEG ratio tell investors?
CVS Health Corp's PEG ratio is 0.67. A PEG ratio below 1.0 is generally considered favorable and may indicate the stock is undervalued when considering both current earnings and expected growth.
How volatile is CVS compared to the overall market?
CVS Health Corp's beta value is 0.60. A beta below 1 indicates the stock is less volatile than the market. For example, if the market moves 10%, you might expect this stock to move less than 10%.

Performance & Growth

Profit Margin

1.40%

Operating Margin

3.50%

Return on Equity

6.93%

Return on Assets

2.31%

Revenue Growth (YoY)

6.90%

Earnings Growth (YoY)

60.20%

How profitable is CVS compared to its industry peers?
CVS Health Corp has a profit margin of 1.40%. This profit margin is on the lower side. The company is keeping $1.40 in profit for every $100 in sales, which could indicate competitive pressures or cost challenges. Profit margins vary by industry, and RETAIL-DRUG STORES AND PROPRIETARY STORES companies typically need to be evaluated against their specific sector benchmarks.
What do CVS's ROE and ROA figures tell investors?
CVS Health Corp has a Return on Equity (ROE) of 6.93% and a Return on Assets (ROA) of 2.31%. The ROE is moderate, showing reasonable efficiency in utilizing shareholders' capital. The ROA indicates there may be room for improvement in how efficiently assets are being used. The relatively balanced ROE and ROA suggest the company isn't overly reliant on debt to boost returns.
Is CVS growing faster or slower than in previous periods?
CVS Health Corp's year-over-year quarterly revenue growth is 6.90%. This indicates positive revenue momentum, though at a moderate pace. Meanwhile, earnings growth is 60.20% year-over-year. Earnings are growing faster than revenue, suggesting improving profit margins or operational efficiency.
What does CVS's operating margin tell us about its business model?
CVS Health Corp's operating margin is 3.50%. This operating margin is on the lower side, which might reflect intense competition, high operational costs, or a business model that requires high volume to compensate for thin margins. Operating margins vary widely by industry, and in the retail-drug stores and proprietary stores sector, margins are often lower due to competition and higher variable costs.

Dividend Information

Dividend Per Share

$2.66

Dividend Yield

4.15%

Ex-Dividend Date

4/22/2025

Dividend Date

5/1/2025

How does CVS's dividend yield compare to other investments?
CVS Health Corp's dividend yield is currently 4.15%. This is considered a high dividend yield that exceeds both the S&P 500 average (typically around 1.5-2%) and 10-year Treasury bonds. This may make it attractive for income-focused investors. In the retail-drug stores and proprietary stores industry, this yield should be evaluated against industry peers for a meaningful comparison.
What do the ex-dividend and dividend dates mean for CVS investors?
The next ex-dividend date for CVS Health Corp is 4/22/2025. This is the cut-off date for receiving the upcoming dividend. Investors who purchase shares before this date will receive the dividend, while those who buy on or after this date will not. The actual payment of this dividend will occur on 5/1/2025. The dividend amount is $2.66 per share.
How sustainable is CVS's dividend?
CVS Health Corp pays a dividend of $2.66 per share, with trailing twelve month earnings of $4.19 per share. This gives a dividend payout ratio of approximately 63.48%. This relatively high payout ratio means a significant portion of earnings goes to dividends, leaving less for reinvestment.

Company Size & Market

Market Cap

$81.01B

Shares Outstanding

1.27B

Book Value/Share

$60.96

Asset Type

Common Stock

What does CVS's market capitalization tell investors?
CVS Health Corp's market capitalization is $81.01B, which makes it a large-cap company. Large-caps are generally considered more stable investments with established business models and often pay regular dividends. Within the retail-drug stores and proprietary stores industry, this market cap places CVS Health Corp among the significant companies in the industry.
What's the significance of CVS's book value per share?
CVS Health Corp's book value per share is $60.96, while its current market price is $66.06. This gives a price-to-book (P/B) ratio of 1.08. This P/B ratio is moderate and suggests investors are paying a reasonable premium above the company's accounting value, which may reflect expectations of future growth or profitability. In the retail-drug stores and proprietary stores industry, this P/B ratio should be compared to industry peers for context.
How does the number of outstanding shares affect CVS investors?
CVS Health Corp has 1.27B outstanding shares. The number of outstanding shares directly affects metrics like earnings per share (EPS) and can be influenced by corporate actions such as stock splits, buybacks, or new share issuances. With a market cap of $81.01B, each share represents ownership of approximately $64.04 of the company's total value. When companies reduce their outstanding shares through buyback programs, this can increase EPS and potentially support higher share prices, assuming other factors remain constant. Conversely, when new shares are issued, this can dilute existing shareholders' ownership stakes.

Analyst Ratings

Analyst Target Price

$79.61

20.51% upside potential

Analyst Recommendations

Strong Buy

7

Buy

12

Hold

9

Sell

0

Strong Sell

0

How should I interpret analysts' recommendations for CVS?
For CVS Health Corp, analysts have provided the following recommendations: 7 Strong Buy, 12 Buy, 9 Hold,00 Analyst recommendations reflect professional opinions about a stock's potential performance, but they should be just one factor in your investment decisions. Each analyst may use different methodologies and timeframes for their assessments. Overall, analysts currently have a positive view on this stock.
What does the analyst target price mean for CVS?
The consensus analyst target price for CVS Health Corp is $79.61, compared to its current price of $66.06. This represents a potential upside of 20.51%. Analyst target prices typically reflect where professionals expect the stock price to be in 12 months. This consensus target is derived from individual price targets set by various analysts covering the stock, and it may be updated as market conditions change or as new information becomes available. Keep in mind that while target prices provide insight into professional expectations, they are not guarantees, and actual price performance can vary significantly from these targets.
How accurate are analyst forecasts for stocks like CVS?
Analyst forecasts, while informative, have inherent limitations in their accuracy. Studies have shown that analysts' predictions can be influenced by various biases, including optimism bias (tendency to be overly positive) and herding behavior (following other analysts' opinions). In the retail-drug stores and proprietary stores industry, forecasts may be particularly challenging due to factors like changing market conditions, competitive dynamics, regulatory changes, and macroeconomic shifts.
Historically, analysts have been more accurate when forecasting:
  • Stable, mature companies with predictable earnings
  • Near-term results rather than long-term performance
  • Companies with transparent business models
Consider analyst forecasts as one tool among many in your investment research, and evaluate them alongside other metrics, industry trends, and your own assessment of the company's fundamentals and market position.

Fundamentals last updated: Jun 2, 2025, 08:18 AM

Technical Indicators

RSI (14-day)

49.61

Neutral

50-Day Moving Average

$65.20

1.32% above MA-50

200-Day Moving Average

$58.59

12.75% above MA-200

MACD Line

-0.56

MACD Signal

-0.85

MACD Histogram

0.29

Bullish

What does CVS's RSI value tell investors?
CVS Health Corp's current Relative Strength Index (RSI) is 49.61. This indicates neutral momentum as the RSI is in the middle range. Values around 50 suggest no clear directional bias. The RSI is a momentum oscillator that measures the speed and change of price movements on a scale from 0 to 100. It's used to identify overbought or oversold conditions and potential reversals.
How should I interpret CVS's moving averages?
CVS Health Corp's current price of $66.06 is above both its 50-day moving average ($65.20) and its 200-day moving average ($58.59). This is typically considered bullish, indicating the stock is in an uptrend across both short and long-term timeframes. Additionally, the 50-day moving average is above the 200-day moving average, forming what traders call a 'golden cross,' which is generally considered a bullish signal. Moving averages smooth out price data to create a single flowing line, making it easier to identify the direction of the trend. The 50-day MA represents medium-term trend, while the 200-day MA reflects the long-term trend.
What is the MACD indicating about CVS's momentum?
For CVS Health Corp, the MACD Line is -0.56, the Signal Line is -0.85, and the MACD Histogram is 0.29. The positive MACD histogram indicates bullish momentum, with the MACD line above the signal line. This suggests buying pressure is currently stronger than selling pressure. The MACD (Moving Average Convergence Divergence) is a trend-following momentum indicator that shows the relationship between two moving averages of a security's price. The MACD line is calculated by subtracting the 26-period EMA from the 12-period EMA. The signal line is a 9-period EMA of the MACD line, and the histogram represents the difference between the MACD line and the signal line.

Indicators last updated: Jun 5, 2025, 12:41 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for CVS and get notified when the price changes.

Stay Ahead of the Market with CVS Health Corp Alerts

Set up price alerts for CVS Health Corp and get notified instantly when the price hits your target. Never miss an important price movement again.